Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Background: The role of hepatic resection in the treatment of type I and II hilar cholangiocarcinoma (HCCA) remains controversial. In the present study, we aimed to identify whether hepatic resection was necessary for type I and II HCCA.
Methods: A total of 23 patients classified as type I and II HCCA undergoing surgical resection were included in this study. The patients were divided into two groups: bile duct resection (BDR) group (n = 15) and hepatic resection (HR) group (n = 8). Systematic review and meta-analysis were performed to compare the R0 resection and long-term survival between BDR and HR for Bismuth type I and II HCCA. A total of 7 studies with 260 cases were included in this meta-analysis.
Results: In our cohort, the R0 resection rate was 73.3% in BDR group and 87.5% in HR group. The HR group had a higher number of postoperative complications than the BDR group (P = 0.002). There was no difference in long-term survival (P = 0.544) and recurrence (P = 0.846) between BDR and HR in Bismuth type I and II HCCA. The meta-analysis showed that HR was associated with better R0 resection rate (RR 4.45, 95% CI 2.34-8.48) and overall survival (HR 2.15, 95% CI 1.34-3.44) compared with BDR group. There was no publication bias and undue influence of any single study.
Conclusions: The meta-analysis showed that HR was associated with better R0 resection rate and overall survival compared with BDR for type I and II HCCA patients. More aggressive surgical strategies should be increasingly considered for the treatment of type I and II HCCA patients.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1245/s10434-020-08453-2 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Expression of PDZ domain-containing proteins is correlated with prognosis and immune infiltration in hepatocellular carcinoma.
J Gastrointest Oncol
June 2025
Department of Gastroenterology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Background: Hepatocellular carcinoma (HCC)-a predominant type of primary liver cancer-poses a significant global health threat with high incidence and mortality rates. Despite advances in treatment modalities, including surgery, chemotherapy, and immunotherapy, HCC exhibits high relapse rates and low long-term survival, necessitating the identification of novel prognostic markers and treatment targets. This study aims to develop a prognostic model centered on the PDZ domain by identifying key PDZ proteins associated with HCC through bioinformatics analysis of large-scale public datasets, in order to improve prognosis prediction and inform therapeutic strategies.
View Article and Find Full Text PDFClinical significance of tumor infiltration length along the bile duct mucosa and submucosa in hilar cholangiocarcinoma.
Chin Clin Oncol
April 2025
Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation and Department of Biliary-Pancreatic Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
Background: Radical resection remains the mainstay of treatment for patients with hilar cholangiocarcinoma (HCCA), however, the scope of resection remains controversial. This study investigates the influence of tumor infiltration length along the mucosa and submucosa of the bile duct on curative resection.
Methods: The clinical and pathological data of 31 HCCA patients who underwent en bloc and extended liver resection in the Department of Biliary-Pancreatic Surgery of Sun Yat-sen Memorial Hospital from January 2020 to December 2021 were retrospectively analyzed.
Does caudate lobe resection really improve the surgical outcomes of patients with hilar cholangiocarcinoma? A multicenter retrospective study.
Sci China Life Sci
July 2025
Hepatic Surgery Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
In the field of hilar cholangiocarcinoma (HCCA) treatment, the value of caudate lobe resection (CLR) has not been fully elucidated. Most scholars advocate that the caudate lobe should be routinely resected. To further investigate this issue, this study aims to evaluate the impact of CLR on surgical outcomes of HCCA patients who are judged to have no obvious tumor invasion in the caudate lobe.
View Article and Find Full Text PDFFeasibility and safety of robotic radical resection for hilar cholangiocarcinoma in highly selected patients: A systematic review and meta-analysis with meta-regression.
Ann Hepatobiliary Pancreat Surg
May 2025
Department of Hepatobiliary and Pancreatic Surgery, Manchester Royal Infirmary Hospital, Manchester, UK.
To examine the feasibility and safety of robotic radical resection (RRR) for hilar cholangiocarcinoma (HCCA). A PRISMA-compliant meta-analysis with meta-regression was conducted, including studies reporting outcomes of RRR in patients with HCCA. Six studies comprising 295 patients were included.
View Article and Find Full Text PDFmiR-182-5p promotes the proliferation and invasion of hilar cholangiocarcinoma cells by inhibiting FBXW7.
J Cancer Res Clin Oncol
October 2024
Department of Hepatobiliary Surgery, The First Affiliated Hospital of Chongqing Medical University, No. 50, Jinyu Avenue, Liangjiang New Area, Chongqing, 400016, China.
Article Synopsis
- Hilar cholangiocarcinoma (HCCA) is a prevalent cancer affecting the biliary tract, and this study aims to explore the role of a molecule called miR-182-5p in its growth and spread.
- Researchers cultured HCCA cells, transfected them with a miR-182-5p inhibitor, and conducted various assays to observe the effects on cell behavior and the relationship between miR-182-5p and a protein called FBXW7.
- The findings revealed that high levels of miR-182-5p in HCCA promote cell growth and invasion by suppressing FBXW7, and inhibiting miR-182-5p showed potential in slowing down tumor growth